Based upon its current operating plan and inclusive of the net cash proceeds from the October financing and milestone payment from Roche, Synlogic expects to have sufficient cash to be able to fund operations further into the first half of 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SYBX:
- Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Synlogic achieves research milestone, earns $2.5M milestone payment
- Is SYBX a Buy, Before Earnings?
- Synlogic Announces Closing of $21.0 Million Underwritten Public Offering
- Synlogic prices 7.39M shares at $2.84 in underwritten public offering